Skip to main content
RISE logo

In vitro methods for immunotoxicology, cellular toxicology, efficacy markers and ADME parameters

Our wide selection of in vitro models help you confirm and optimise pharmacological effects, to predict and analyse toxic effects and to study ADME properties of drugs in different phases of development. Toxicological assessment of industrial chemicals using in vitro techniques is also included in our range of services.

Experience and competence

Our experts have collectively more than 50 years of experience in drug development and are well versed in appropriate safety assessment legislations, allowing them to assist you in moving your project further on the value chain. 

Our tests are based on regulatory requirements and international guidelines and practices but we are flexible in providing tailor-made test models according to your specific requirements. 

Project support and risk mitigation

Our in vitro laboratory provides expert assistance in assessment, prediction and/or interpretation of  toxicological effects in the immune system and various organs (e.g liver and kidney), as well as providing essential ADME parameters. Since computer-based (in silico) and GLP certified in vivo capabilities are also operating within our facilities, your project will automatically have access to these areas of expertise and test systems when you contact us. For example, an effect demonstrated during in vitro testing can be further investigated in vivo and again followed-up by ex vivo verifications in the in vitro laboratory. Further, data from in vitro experimentation can also be fed into various in silico tools for enhancing their predictive capacity. All data derived within your project is thus handled within the same unit and data integration and problem-solving activities can proceed without you as the customer losing time in forwarding information between different contract laboratories.

As well as providing experimental data in vitro, each project is supported by extensive ability to rationalise data in terms of potential mechanism(s) of toxicity, and translatability between species. We also help you to interpret regulatory requirements and guidelines from government agencies (ICH, EMA, FDA, OECD), to ensure that the choice of models is fit for purpose for your project from a regulatory perspective.


We test both low molecular weight and biological drug candidates, as well as industrial chemicals and the test models deliver both functional- and quantitative data. GLP is available upon request. Examples of the “off the shelf” tests we perform are clustered below under various areas of toxicity:

Immunotoxicology and immunological effects

Test systems related to both innate and acquired immunity are included in our offer and provide, for example, cytokine measurements, antibody measurements, immune phenotyping, detection of memory cells, lymphocyte activation, phagocytosis, oxidative burst, NK cell activity, T-cell dependent antibody-response (in vivo trials included), histamine release, ADCC, CDC and prediction of immunogenicity (in silico testing included). Other test models can be ordered as desired. Fit for purpose efficacy models for drugs can also be designed, depending on therapeutic target.

Liver toxicology

We can offer testing/screening of drug candidates for potential mitochondrial toxicity and hepatotoxicity in the state of the art Glu/Gal HepG2 method used by big Pharma. We can also offer assays in frozen or fresh human hepatocytes. These in vitro methods are recommended if the substance has previously given a positive prediction for hepatotoxicity potential from in silico methods, which are also available in-house. In our in vivo studies, we can perform histopathological evaluation on the liver and also monitor the development of liver damage by studying plasma biomarkers which include both traditional markers such as ALT  in combination with newly validated markers such as GLDH, CSF1R, miR-122  and  HMGB1.


We can measure plasma protein binding and perform metabolic stability studies in microsomes from relevant species. We also offer intellectual support in evaluating ADME data and integrating these in risk predictions and risk assessments.


  • Cholesterol efflux
  • PCR-testing
  • Hybridization ELISA

More information

We also carry out verification tests on diagnostic point-of-care analyses. A current assignment includes verification of rapid-tests for measurement of SARS-Cov-2 specific antibodies.

Anders Kallin

Contact person

Anders Kallin

Försöksledare Projektledare

+46 10 516 62 72

Read more about Anders

Contact Anders
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.

* Mandatory By submitting the form, RISE will process your personal data.

Contact person

Ian Cotgreave

Senior forskare

+46 10 516 63 81

Read more about Ian

Contact Ian
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.

* Mandatory By submitting the form, RISE will process your personal data.


Cannot find what you are looking for or are you curious about how we can help?

Send message
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.

* Mandatory By submitting the form, RISE will process your personal data.




An aging population means that more people are dealing with chronic diseases. Many illnesses still lack treatment, but we also see new opportunities for treatment, cure and a healthier life through precision medicine, bi…

Chemical and biological analysis

Chemical and biological analyses are essential tools for most types of research, development and production. We provide industry-specific analytical services and expertise across a wide range of fields; for example, industrial pro…

Life Science

The world is facing societal health challenges, such as pandemics, demographic changes, antibiotic resistance, and unequal care. In Europe in 2024, people aged 65 and older will outnumber the under 15s and by 2060 the over 80s is …

Artificial intelligence

Wouldn’t it be convenient if your computer could find you your next job or if your doctor could make a diagnosis before you felt ill? Artificial intelligence (AI) is the science of intelligent machines and the technology to create…

Bioanalysis and pharmaceuticals

Bioanalysis is used for assessments of efficacy, metabolism, kinetics, and toxicity. We have the expertise required to select, validate and measure adequate biomarkers for your study. RISE ensures quality throughout the bioanalyti…

Toxicological tests and safety

We can test and assess the potential toxicities/hazards of emerging drug candidates, industrial chemicals, food additives and medical devices, contributing to safety assessments required for market approvals. We can also support i…